Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recent patents on alphavirus protein expression and vector production.
Aranda A, Ruiz-Guillen M, Quetglas JI, Bezunartea J, Casales E, Smerdou C. Aranda A, et al. Among authors: bezunartea j. Recent Pat Biotechnol. 2011 Dec;5(3):212-26. doi: 10.2174/187220811797579060. Recent Pat Biotechnol. 2011. PMID: 22360469 Review.
Alphavirus vectors for cancer therapy.
Quetglas JI, Ruiz-Guillen M, Aranda A, Casales E, Bezunartea J, Smerdou C. Quetglas JI, et al. Among authors: bezunartea j. Virus Res. 2010 Nov;153(2):179-96. doi: 10.1016/j.virusres.2010.07.027. Epub 2010 Aug 6. Virus Res. 2010. PMID: 20692305 Review.
Capsid-deficient alphaviruses generate propagative infectious microvesicles at the plasma membrane.
Ruiz-Guillen M, Gabev E, Quetglas JI, Casales E, Ballesteros-Briones MC, Poutou J, Aranda A, Martisova E, Bezunartea J, Ondiviela M, Prieto J, Hernandez-Alcoceba R, Abrescia NG, Smerdou C. Ruiz-Guillen M, et al. Among authors: bezunartea j. Cell Mol Life Sci. 2016 Oct;73(20):3897-916. doi: 10.1007/s00018-016-2230-1. Epub 2016 Apr 27. Cell Mol Life Sci. 2016. PMID: 27117550 Free PMC article.
Idiotype vaccines produced with a non-cytopathic alphavirus self-amplifying RNA vector induce antitumor responses in a murine model of B-cell lymphoma.
Casales E, Martisova E, Villanueva H, de Cerio ALD, Inoges S, Silva-Pilipich N, Ballesteros-Briones MC, Aranda A, Bezunartea J, Bendandi M, Pastor F, Smerdou C. Casales E, et al. Among authors: bezunartea j. Sci Rep. 2021 Nov 2;11(1):21427. doi: 10.1038/s41598-021-00787-5. Sci Rep. 2021. PMID: 34728659 Free PMC article.
Adjuvant combination and antigen targeting as a strategy to induce polyfunctional and high-avidity T-cell responses against poorly immunogenic tumors.
Aranda F, Llopiz D, Díaz-Valdés N, Riezu-Boj JI, Bezunartea J, Ruiz M, Martínez M, Durantez M, Mansilla C, Prieto J, Lasarte JJ, Borrás-Cuesta F, Sarobe P. Aranda F, et al. Among authors: bezunartea j. Cancer Res. 2011 May 1;71(9):3214-24. doi: 10.1158/0008-5472.CAN-10-3259. Epub 2011 Mar 14. Cancer Res. 2011. PMID: 21402711 Free article.
In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-beta1.
Gil-Guerrero L, Dotor J, Huibregtse IL, Casares N, López-Vázquez AB, Rudilla F, Riezu-Boj JI, López-Sagaseta J, Hermida J, Van Deventer S, Bezunartea J, Llopiz D, Sarobe P, Prieto J, Borrás-Cuesta F, Lasarte JJ. Gil-Guerrero L, et al. Among authors: bezunartea j. J Immunol. 2008 Jul 1;181(1):126-35. doi: 10.4049/jimmunol.181.1.126. J Immunol. 2008. PMID: 18566377 Free article.
22 results